Torii Pharmaceutical Co., Ltd. (4551.T)
JPY 4680.0
(2.18%)
JPY 4680.0
(2.18%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 19.53 Billion JPY | 9.54% |
| 2022 | 17.83 Billion JPY | -9.37% |
| 2021 | 19.67 Billion JPY | 15.79% |
| 2020 | 16.99 Billion JPY | -18.53% |
| 2019 | 20.86 Billion JPY | -18.99% |
| 2018 | 25.75 Billion JPY | -3.03% |
| 2017 | 26.55 Billion JPY | 1.76% |
| 2016 | 26.09 Billion JPY | -2.05% |
| 2015 | 26.64 Billion JPY | 41.1% |
| 2014 | 18.88 Billion JPY | -29.68% |
| 2013 | 26.85 Billion JPY | 0.74% |
| 2012 | 26.65 Billion JPY | 10.97% |
| 2011 | 24.01 Billion JPY | 15.46% |
| 2010 | 20.8 Billion JPY | 27.58% |
| 2009 | 16.3 Billion JPY | 8.35% |
| 2008 | 15.04 Billion JPY | -5.35% |
| 2007 | 15.89 Billion JPY | 2.61% |
| 2006 | 15.49 Billion JPY | 4.89% |
| 2005 | 14.77 Billion JPY | 2.11% |
| 2004 | 14.46 Billion JPY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q3 | 5.27 Billion JPY | 7.92% |
| 2024 Q2 | 4.88 Billion JPY | 6.68% |
| 2024 Q1 | 4.58 Billion JPY | -7.14% |
| 2023 Q3 | 4.4 Billion JPY | -1.19% |
| 2023 FY | 19.53 Billion JPY | 9.54% |
| 2023 Q4 | 4.93 Billion JPY | 11.96% |
| 2023 Q2 | 4.45 Billion JPY | -25.18% |
| 2023 Q1 | 5.95 Billion JPY | 19.57% |
| 2022 Q3 | 4.48 Billion JPY | 2.51% |
| 2022 Q2 | 4.37 Billion JPY | 9.59% |
| 2022 FY | 17.83 Billion JPY | -9.37% |
| 2022 Q1 | 3.99 Billion JPY | -28.59% |
| 2022 Q4 | 4.98 Billion JPY | 11.1% |
| 2021 FY | 19.67 Billion JPY | 15.79% |
| 2021 Q4 | 5.59 Billion JPY | 16.02% |
| 2021 Q1 | 4.41 Billion JPY | -10.49% |
| 2021 Q2 | 4.86 Billion JPY | 10.18% |
| 2021 Q3 | 4.81 Billion JPY | -0.86% |
| 2020 Q4 | 4.92 Billion JPY | 11.32% |
| 2020 Q1 | 3.86 Billion JPY | -23.41% |
| 2020 Q2 | 3.77 Billion JPY | -2.48% |
| 2020 Q3 | 4.42 Billion JPY | 17.36% |
| 2020 FY | 16.99 Billion JPY | -18.53% |
| 2019 Q3 | 5.2 Billion JPY | 1.4% |
| 2019 Q4 | 5.05 Billion JPY | -2.96% |
| 2019 FY | 20.86 Billion JPY | -18.99% |
| 2019 Q1 | 5.47 Billion JPY | -19.52% |
| 2019 Q2 | 5.13 Billion JPY | -6.26% |
| 2018 Q3 | 6.34 Billion JPY | -0.78% |
| 2018 FY | 25.75 Billion JPY | -3.03% |
| 2018 Q1 | 6.2 Billion JPY | -12.54% |
| 2018 Q4 | 6.8 Billion JPY | 7.18% |
| 2018 Q2 | 6.39 Billion JPY | 3.09% |
| 2017 Q2 | 6.67 Billion JPY | 6.44% |
| 2017 FY | 26.55 Billion JPY | 1.76% |
| 2017 Q4 | 7.09 Billion JPY | 8.84% |
| 2017 Q3 | 6.51 Billion JPY | -2.31% |
| 2017 Q1 | 6.26 Billion JPY | -7.32% |
| 2016 Q2 | 6.56 Billion JPY | 7.93% |
| 2016 Q1 | 6.07 Billion JPY | -17.89% |
| 2016 FY | 26.09 Billion JPY | -2.05% |
| 2016 Q4 | 6.76 Billion JPY | 1.03% |
| 2016 Q3 | 6.69 Billion JPY | 2.06% |
| 2015 FY | 26.64 Billion JPY | 41.1% |
| 2015 Q4 | 7.4 Billion JPY | 15.1% |
| 2015 Q3 | 6.43 Billion JPY | -3.38% |
| 2015 Q2 | 6.65 Billion JPY | 8.17% |
| 2015 Q1 | 6.15 Billion JPY | 0.0% |
| 2014 Q3 | 6.13 Billion JPY | 2.88% |
| 2014 Q1 | 6.77 Billion JPY | -3.19% |
| 2014 FY | 18.88 Billion JPY | -29.68% |
| 2014 Q2 | 5.96 Billion JPY | -11.96% |
| 2013 Q4 | 6.99 Billion JPY | 5.74% |
| 2013 FY | 26.85 Billion JPY | 0.74% |
| 2013 Q1 | 6.86 Billion JPY | -0.95% |
| 2013 Q2 | 6.46 Billion JPY | -5.79% |
| 2013 Q3 | 6.61 Billion JPY | 2.38% |
| 2012 Q4 | 6.92 Billion JPY | 7.33% |
| 2012 FY | 26.65 Billion JPY | 10.97% |
| 2012 Q1 | 12.44 Billion JPY | 252.74% |
| 2012 Q2 | 6.41 Billion JPY | -48.44% |
| 2012 Q3 | 6.45 Billion JPY | 0.61% |
| 2011 FY | 24.01 Billion JPY | 15.46% |
| 2011 Q2 | 3.47 Billion JPY | -70.02% |
| 2011 Q3 | 4.57 Billion JPY | 31.88% |
| 2011 Q4 | 3.52 Billion JPY | -22.97% |
| 2011 Q1 | 11.58 Billion JPY | 253.97% |
| 2010 Q2 | 2.81 Billion JPY | -62.85% |
| 2010 FY | 20.8 Billion JPY | 27.58% |
| 2010 Q4 | 3.27 Billion JPY | 4.5% |
| 2010 Q3 | 3.13 Billion JPY | 11.15% |
| 2010 Q1 | 7.58 Billion JPY | 155.63% |
| 2009 Q1 | 7.2 Billion JPY | 165.68% |
| 2009 Q2 | 2.84 Billion JPY | -60.53% |
| 2009 Q3 | 2.91 Billion JPY | 2.6% |
| 2009 Q4 | 2.96 Billion JPY | 1.71% |
| 2009 FY | 16.3 Billion JPY | 8.35% |
| 2008 Q4 | 2.71 Billion JPY | 2.92% |
| 2008 Q3 | 2.63 Billion JPY | 0.0% |
| 2008 FY | 15.04 Billion JPY | -5.35% |
| 2007 FY | 15.89 Billion JPY | 2.61% |
| 2006 FY | 15.49 Billion JPY | 4.89% |
| 2005 FY | 14.77 Billion JPY | 2.11% |
| 2004 FY | 14.46 Billion JPY | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 43.63 Billion JPY | 55.23% |
| Takeda Pharmaceutical Company Limited | 2618.18 Billion JPY | 99.254% |
| Sumitomo Pharma Co., Ltd. | 542.17 Billion JPY | 96.397% |
| Shionogi & Co., Ltd. | 197.62 Billion JPY | 90.114% |
| Wakamoto Pharmaceutical Co.,Ltd. | 3.73 Billion JPY | -422.889% |
| Nippon Shinyaku Co., Ltd. | 65.63 Billion JPY | 70.232% |
| Kaken Pharmaceutical Co., Ltd. | 29.02 Billion JPY | 32.691% |
| Eisai Co., Ltd. | 533.01 Billion JPY | 96.335% |
| Morishita Jintan Co., Ltd. | 5.28 Billion JPY | -269.879% |
| Hisamitsu Pharmaceutical Co., Inc. | 65.8 Billion JPY | 70.31% |
| Mochida Pharmaceutical Co., Ltd. | 46.26 Billion JPY | 57.773% |
| Fuso Pharmaceutical Industries,Ltd. | 11.55 Billion JPY | -69.108% |
| Nippon Chemiphar Co., Ltd. | 8.23 Billion JPY | -137.33% |
| Tsumura & Co. | 48.8 Billion JPY | 59.965% |
| Kissei Pharmaceutical Co., Ltd. | 33.32 Billion JPY | 41.373% |
| Towa Pharmaceutical Co., Ltd. | 63.73 Billion JPY | 69.347% |
| Fuji Pharma Co., Ltd. | 12.65 Billion JPY | -54.357% |
| Zeria Pharmaceutical Co., Ltd. | 40.46 Billion JPY | 51.718% |
| KYORIN Holdings, Inc. | 45.39 Billion JPY | 56.962% |
| Taiko Pharmaceutical Co.,Ltd. | 4.15 Billion JPY | -369.978% |
| Daito Pharmaceutical Co.,Ltd. | 5.94 Billion JPY | -228.629% |
| SymBio Pharmaceuticals Limited | 5.22 Billion JPY | -274.08% |
| MedRx Co., Ltd | 959 Million JPY | -1937.226% |
| Mizuho Medy Co.,Ltd. | 2.87 Billion JPY | -579.848% |
| Solasia Pharma K.K. | 1.47 Billion JPY | -1223.645% |
| Modalis Therapeutics Corporation | 2.37 Billion JPY | -724.115% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | 24.16 Billion JPY | 19.152% |
| Sawai Group Holdings Co., Ltd. | 35.43 Billion JPY | 44.862% |
| Cyfuse Biomedical K.K. | 735.18 Million JPY | -2557.441% |
| Toho Holdings Co., Ltd. | 99.81 Billion JPY | 80.427% |
| Koa Shoji Holdings Co.,Ltd. | 2.25 Billion JPY | -765.508% |